Ojemda® approved in the European Union as the first targeted...

Ipsen announces that Beech Tree has obtained an exemption from...

Ipsen announces the availability of its 2025 Universal Registration Document

Ipsen – February 2026 – Monthly information relative to the...

Ipsen appoints Michelle C. Werner as EVP, President of North...

Ipsen – January 2026 – Monthly information relative to the...

Ipsen nominates Peter Guenter to its Board of Directors

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma

Ipsen – December 2025 – Monthly information relative to the...

Ipsen – Half year statement – 2025 12 31